Sponsor Pipeline

Hyungwoo Cho Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07062627 Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma Primary CNS Lymphoma (PCNSL) Recruiting
Disease Areas
DLBCL (1)
Get alerts when Hyungwoo Cho's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free